Tianjin Ringpu Bio-Technology (300119.SZ), on the investor interactive platform, indicated that the company plans to launch poultry-use Jiubibing extract powder and Radix codonopsis pilosulae oral liquid, rumen-use gentamicin injection and Levamisole hydrochloride injection, pet-use Dichlorvos Pyrethrins Drops and cyclosporine oral solution in the drug sector in the second half of the year; while in biological product sector, the company plans to launch Bovine Bacillus vaccine, duck plague recombinant H5 live vaccine, Porcine circovirus inactivated vaccine, Porcine circovirus subunit vaccine, etc.
瑞普生物(300119.SZ)：下半年药物板块计划推出禽用救必应提取物散等
Tianjin Ringpu Bio-Technology (300119.SZ) plans to launch chicken-specific Jiebibing extract powder and other drugs in the second half of the year.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.